Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
We've covered a wide range of topics in our "ASCO 2012 Lung Cancer Highlights" podcast series over the last few weeks. This webinar and the podcasts from it featured Drs. Mark Socinski from the University of Pittsburgh and Joel Neal from Stanford Cancer Center; following their presentations, they did a question and answer session together, covering a wide range of leading topics in lung cancer from ASCO. Here's that Q&A session.
ASCO 2012 LC Highlights QA Session Audio Podcast
ASCO 2012 LC Highlights QA Session Transcript
ASCO 2012 LC Highlights QA Session Figs
That's the end of this series, and we again thank LUNGevity Foundation for partnering with us to make it possible. I hope you found it valuable. If there was a favorite topic, or one that didn't get a mention that you hoped would, please let us know with a comment.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…